There are at least two side effects of CP-based therapy: 1) CP could stimulate ERK activation and thus might promote cancer cell survival; 2) Hyperglycemia is one of the most highly occurred adverse events in clinical trials, which might benefit tumor cell growth. The gene discussed is CP; the disease is Hyperglycemia.